Advertisement
UK markets open in 5 minutes

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,790.77
    +279.08 (+1.69%)
     

  • CRUDE OIL

    83.02
    +0.17 (+0.21%)
     

  • GOLD FUTURES

    2,314.60
    -31.80 (-1.36%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • Bitcoin GBP

    53,790.23
    +31.62 (+0.06%)
     

  • CMC Crypto 200

    1,402.15
    -12.61 (-0.89%)
     

  • NASDAQ Composite

    15,451.31
    +169.30 (+1.11%)
     

  • UK FTSE All Share

    4,362.60
    +66.19 (+1.54%)
     
Stock:

Trending tickers

Tesla, Nvidia, Tencent, Fresnillo

Merck KGaA's lab supplies unit sees Q3 EBITDA jump 30.7%

Reuters
Updated ·1-min read
FILE PHOTO: The logo of German pharmaceuticals company Merck is seen at the company's headquarters in Darmstadt

FRANKFURT (Reuters) - Germany's Merck KGaA said its Life Science unit, which supplies materials and gear to makers of vaccines and drugs, saw adjusted earnings jump 30.7% in the third quarter, driven by demand related to COVID-19.

Earnings before interest, taxes, depreciation and amortisation (EBITDA), adjusted for one-off items, for the division reached 824 million euros, the diversified group reported on Thursday.

In an unscheduled release last week, Merck raised its full-year profit forecast, citing very strong performance at its Life Science unit, and published forecast-beating group earnings for the quarter.

(Reporting by Ludwig Burger)